Liver fat volume fraction quantification with fat and water T1 and T2*estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T

European Radiology

Volumn 23, Issue 8, 2013, Pages 2175-2186

  Leporq, Benjamin ^a   Ratiney, Hélène ^a   Pilleul, Frank ^a,b,c   Beuf, Olivier ^a  

^a UNIVERSITÉ DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Chronic liver diseases; Fat quantification; MRI; NAFLD; NASH

Indexed keywords

FAT; WATER;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EMULSION; FAT CONTENT; FAT VOLUME FRACTION; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

ADIPOSE TISSUE; ADULT; AGED; ALGORITHMS; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, THEORETICAL; PHANTOMS, IMAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84880327919     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2826-x     Document Type: Article

References (44)

1. Szczepaniak L, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:462-468
2. Ratziu V, Bellentani S, Cortez-Pinto H et al (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372-384
3. Bedogni G, Miglioli L, Masutti F et al (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44-52
4. Reilly JJ (2006) Diagnostic accuracy of the BMI for age in paediatrics. Int J Obes 30:595-597
5. Stamatakis E, Primatesta P, Chinn S, Rona R, Falascheti E (2005) Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors? Arch Dis Child 90:999-1004
6. Harrison SA, Neuschwander-Tetri BA (2004) Non alcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 8:861-879
7. Sanyal AJ, Banas C, Sargeant C et al (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43:682-689
8. Guzman G, Brunt EM, Petrovic LM et al (2008) Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med 132:1761-1766
9. Lok AS, Everhart JE, Chung RT et al (2009) Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology 49:1828-1837
10. Piccinino F, Sagnelli E, Pasquale G et al (1986) Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165-173
11. Cadranel JF, Rufat P, Degos F et al (2000) Practices of liver biopsy in France: results of prospective nationwide survey. Hepatology 32:477-481
12. Poniachik J, Bernstein DE, Reddy KR et al (1996) The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43:568-571
13. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449-1457
14. El-Badry AM, Breitenstein S, Jochum W et al (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691-697
15. Wong WF, Northrup SR, Herrick RC et al (1994) Quantification of lipid in biological tissue by chemical shift magnetic resonance imaging. Magn Reson Med 32:440-446
16. 1H MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87-97
17. Rinella ME, McCarthy R, Thakrar K et al (2003) Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl 9:851-856
18. Pacifico L, Celestre M, Anania et al (2007) MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 96:542-547
19. Schuchmann S, Weigel C, Albrecht L et al (2007) Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol 62:416-422
20. Cowin GJ, Jonsson JR, Bauer JD et al (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28:937-945
21. Borra RJ, Salo S, Dean K et al (2009) Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 250:130-136
22. Mennesson N, Dumortier J, Hervieu V et al (2009) Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy. J Comput Assist Tomogr 672-677
23. Leporq B, Ratiney H, Cavassila S et al (2010) Fat content quantification errors using multiple gradient echo imaging: a phantom and simulation study. ISMRM-ESMRMB Joint Annual Meeting proceedings
24. Guiu B, Petit JM, Loffroy R et al (2009) Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250:95-102
25. Hussain HK, Chenevert TL, Londy FJ et al (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 237:1048-1055
26. Bydder M, Yokoo T, Hamilton G et al (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347-359
27. Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multi-echo gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67-76
28. Yu H, Shimakawa A, McKenzie CA et al (2008) Multi-echo water-fat separation and simultaneous R2*estimation with multi-frequency fat spectrum modeling. Magn Reson Med 60:1122-1134
29. Yu H, Shimakawa A, Hines CD et al (2011) Combination of complex-based and magnitude-based multi-echo water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 66:199-206
30. Meisamy S, Hines C, Hamilton G, et al. Quantification of hepatic steatosis using T1 independent, T2*corrected MRI with spectral modeling of fat: a blinded comparison with MR spectroscopy. Radiology 258:767-775
31. Hines C, Frydrychowicz A, Hamilton G et al (2011) T1 independent, T2*corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33:873-881
32. 1H MR spectrum. NMR Biomed 24:784-790
33. Reeder SB, Hines CD, Yu H et al (2009) On the definition of fat-fraction for in vivo fat quantification with magnetic resonance imaging. ISMRM proceedings
34. Ratiney H, Bucur A, Sdika M et al (2008) Effective Voigt model estimation using multiple random starting values and parameter bounds settings for in vivo hepatic 1H Magnetic Resonance Spectroscopy data. IEEE International Symposium on Biomedical Imaging proceedings
35. French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsies in patients with chronic hepatitis C. Hepatology 20:15-20
36. Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474
37. De Bazelaire CM, Duhamel GD, Rofsky NM et al (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230:652-659
38. Heye T, Yang SR, Bock M et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22:1224-1232
39. Sirlin CB, Reeder SB (2010) Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 18:359-381
40. Reeder SB, Cruite I, Hamilton G et al (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 33:873-881
41. Thomsen C, Christoffersen P, Henriksen O, Juhl E (1990) Prolonged T1 in patients with liver cirrhosis: an in vivo MRI study. Magn Reson Imaging 8:599-604
42. Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2*mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460-1465
43. Bonkovsky HL, Jawaid Q, Tortorelli K et al (1999) Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 3:421-429
44. Stark DD, Bass NM, Moss AA et al (1983) Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 148:743-751